Hospital Universitario Infanta Cristina; Servicio de Oncologia
About Hospital Universitario Infanta Cristina; Servicio de Oncologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Abbott Medical Devices
2
Castilla-La Mancha Health Service
2
Spanish Breast Cancer Research Group
1
Spanish Oncology Genito-Urinary Group
1
Clinical Trials at Hospital Universitario Infanta Cristina; Servicio de Oncologia
During the past decade, Hospital Universitario Infanta Cristina; Servicio de Oncologia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
2013-08-19
2017-05-05
Completed
296
A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread
2015-03-12
2021-09-17
Terminated
169
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
2019-02-07
2026-12-19
Recruiting
3,400
A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation
2019-12-31
2027-07-16
Active, not recruiting
668
Clinical Efectivity of Two Different Sensor-augmented Pumps With Low Predictive Suspension Function
2021-02-15
2021-06-10
Completed
23
Clinical Efficacy of Insulin Pumps in Type 1 Diabetes Mellitus Patients in Spain
2021-09-01
2021-12-31
Completed
2,977
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Abbott Medical Devices" with 2 trials
sponsored, "Castilla-La Mancha Health Service" with 2 trials sponsored, "Spanish Breast Cancer Research Group" with 1 trials sponsored and "Spanish Oncology Genito-Urinary Group"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Infanta Cristina; Servicio de Oncologia"
#1 collaborator was "Ipsen" with 1 trials as a collaborator, "Seagen Inc." with 1 trials as a collaborator, "Spanish Diabetes Association" with 1 trials as a collaborator and "Syntax for Science, S.L" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hospital Universitario Infanta Cristina; Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" are
"Type 1 Diabetes" (2 trials), "Atrial Fibrillation" (1 trials), "Bradycardia" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario Infanta Cristina; Servicio de Oncologia
Most popular intervention types in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" are "Drug" (6 trials), "Device" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Bevacizumab" (2 trials), "Placebo" (2 trials), "Aveir DR Leadless Pacemaker System" (1 trials) and "Cabozantinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario Infanta Cristina; Servicio de Oncologia
The vast majority of trials in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" are
10 trials for "All" genders.
Clinical Trials Status at Hospital Universitario Infanta Cristina; Servicio de Oncologia
Currently, there are NaN active trials in "Hospital Universitario Infanta Cristina; Servicio de Oncologia".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Universitario Infanta Cristina; Servicio de Oncologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario Infanta Cristina; Servicio de Oncologia, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".